TipRanks
Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh (BR:C1IC34)
:C1IC34
Brazil Market
C1IC34
Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh
RESEARCH TOOLSreports

Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh (C1IC34) Price & Analysis

― Followers

C1IC34 Stock Chart & Stats

R$58.43
-R$0.67(-1.13%)
―
--
Day’s Range― - ―
52-Week Range<R$0.01 - R$70.83
Previous CloseN/A
VolumeN/A
Average Volume (3M)39.00
Market Cap
R$377.05B
Enterprise ValueR$551.42K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)11150.9
Beta0.13
Next Earnings
Oct 29, 2026
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding6,341,771,500
10 Day Avg. Volume15
30 Day Avg. Volume39
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A

Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh News

Cigna backs FY26 adjusted EPS view ‘at least’ $30.45, consensus $30.51
Cigna backs FY26 adjusted EPS view ‘at least’ $30.45, consensus $30.51
Backs FY26: Consolidated adjusted revenues about $280B, consensus $286.76B; Evernorth Health Services pre-tax adjusted income from operations of...
2d ago
CI
Cigna provides 2026-2030 financial targets
Cigna provides 2026-2030 financial targets
Targets: 10%-14% adjusted EPS CAGR; About $50B in cumulative operating cash flow. Published first on TheFly – the...
2d ago
CI
Cigna announces $3B multi-year modernization and productivity initiative
Cigna announces $3B multi-year modernization and productivity initiative
As part of its “Lead to One” vision, The Cigna (CI) Group is announcing a new $3B multi-year...
2d ago
CI
Trump Trade: CMS removes hundreds of thousands from ACA
Trump Trade: CMS removes hundreds of thousands from ACA
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...
9d ago
C
CI
CMS cancels 315,000 unauthorized enrollments in federal health insurance market
CMS cancels 315,000 unauthorized enrollments in federal health insurance market
The Centers for Medicare & Medicaid Services announced it is taking “aggressive, sweeping actions within the Federal Marketplace...
9d ago
CI
CNC
Trump administration to remove hundreds of thousands from ACA, WaPo says
Trump administration to remove hundreds of thousands from ACA, WaPo says
The Trump administration is set to remove hundreds of thousands of Affordable Care Act enrollees, claiming widespread fraud....
10d ago
CI
CNC
Wells Fargo sees rising costs in Managed Care from higher IDR
Wells Fargo sees rising costs in Managed Care from higher IDR
Wells Fargo writes that while Independent Dispute Resolution, or IDR, filings have climbed steadily since early 2025, the...
16d ago
CI
CVS
Uber initiated, Thermo Fisher upgraded: Wall Street’s top analyst calls
Uber initiated, Thermo Fisher upgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here...
23d ago
CI
DYN
Cigna initiated with an In Line at Evercore ISI
Cigna initiated with an In Line at Evercore ISI
Evercore ISI analyst Elizabeth Anderson initiated coverage of Cigna (CI) with an In Line rating and $290 price...
23d ago
CI
Cigna: Buy Rating Reiterated as Specialty Strength Seen Offsetting PBM Headwinds; Price Target Maintained at $361
Cigna: Buy Rating Reiterated as Specialty Strength Seen Offsetting PBM Headwinds; Price Target Maintained at $361
Analyst Erin Wright from Morgan Stanley maintained a Buy rating on Cigna and keeping the price target at...
3d ago
CI
Walmart downgraded, Palantir upgraded: Wall Street’s top analyst calls
Walmart downgraded, Palantir upgraded: Wall Street’s top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here...
2M ago
CI
AIP
Stephen Baxter Maintains Hold on Cigna, Nudges Price Target Up to $307 Amid Strong Healthcare Performance but PBM Uncertainties
Stephen Baxter Maintains Hold on Cigna, Nudges Price Target Up to $307 Amid Strong Healthcare Performance but PBM Uncertainties
In a report released yesterday, Stephen Baxter from Wells Fargo assigned a Hold rating on Cigna, with a...
2M ago
CI
Cigna: Buy Rating Reaffirmed on Durable Growth, Strong PBM and Specialty Performance, with Price Target Unchanged at $378
Cigna: Buy Rating Reaffirmed on Durable Growth, Strong PBM and Specialty Performance, with Price Target Unchanged at $378
Analyst Kevin Fischbeck from Bank of America Securities reiterated a Buy rating on Cigna and keeping the price...
2M ago
CI
Cigna: PBM Transformation and Margin Strength Support Buy Rating with Unchanged $381 Price Target
Cigna: PBM Transformation and Margin Strength Support Buy Rating with Unchanged $381 Price Target
Analyst Lance Wilkes of Bernstein maintained a Buy rating on Cigna, retaining the price target of $381.00. Lance...
2M ago
CI

C1IC34 FAQ

What was Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s price range in the past 12 months?
Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh lowest stock price was <R$0.01 and its highest was R$70.83 in the past 12 months.
    What is Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s market cap?
    Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s market cap is R$377.05B.
      When is Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s upcoming earnings report date?
      Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s upcoming earnings report date is Oct 29, 2026 which is in 27 days.
        How were Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s earnings last quarter?
        Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh released its earnings results on Jul 30, 2026. The company reported R$0.001 earnings per share for the quarter.
          Is Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh overvalued?
          According to Wall Street analysts Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh pay dividends?
            Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh does not currently pay dividends.
            What is Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s EPS estimate?
            Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh have?
            Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh has 6,341,771,500 shares outstanding.
              What happened to Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh’s price movement after its last earnings report?
              Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh reported an EPS of R$0.001 in its last earnings report. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh?
                Currently, no hedge funds are holding shares in BR:C1IC34
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Cigna Group Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh (C1IC34) Earnings & Revenues

                  Historic Earnings Reports

                  Technical Analysis

                  Overall Consensus
                  Strong Sell
                  3Bullish
                  5Neutral
                  14Bearish
                  Bullish
                  Neutral
                  Bearish
                  Overall Consensus
                  3
                  5
                  14
                  Technical Analysis
                  3
                  5
                  2
                  Moving Averages
                  0
                  0
                  12
                  Technical Analysis >
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  A1ON34
                  Aon PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
                  ―
                  ―
                  C1CO34
                  Cencora, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
                  ―
                  ―
                  E1LV34
                  Elevance Health, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
                  ―
                  ―
                  M1MC34
                  Marsh & McLennan Companies, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh
                  ―
                  ―
                  METB34
                  MetLife, Inc. Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh
                  ―
                  ―
                  Compare BR:C1IC34 Stocks >
                  Popular Stocks